[go: up one dir, main page]

MA50113A1 - Procédé et dispositif de discrimination entre des infections virales et bactériennes - Google Patents

Procédé et dispositif de discrimination entre des infections virales et bactériennes

Info

Publication number
MA50113A1
MA50113A1 MA50113A MA50113A MA50113A1 MA 50113 A1 MA50113 A1 MA 50113A1 MA 50113 A MA50113 A MA 50113A MA 50113 A MA50113 A MA 50113A MA 50113 A1 MA50113 A1 MA 50113A1
Authority
MA
Morocco
Prior art keywords
viral
bacterial infections
discriminating
bacterial
relates
Prior art date
Application number
MA50113A
Other languages
English (en)
Other versions
MA50113B1 (fr
Inventor
Detlef Jakschies
Original Assignee
Von Mutius Dietrich
Erber Walter
Jakschies Detle
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Von Mutius Dietrich, Erber Walter, Jakschies Detle filed Critical Von Mutius Dietrich
Publication of MA50113A1 publication Critical patent/MA50113A1/fr
Publication of MA50113B1 publication Critical patent/MA50113B1/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G01N33/54387—Immunochromatographic test strips
    • G01N33/54388—Immunochromatographic test strips based on lateral flow
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4715—Cytokine-induced proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4737—C-reactive protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention concerne une analyse hors laboratoire pour la détection et la différenciation entre des infections virales et bactériennes, qui aident efficacement à la différenciation rapide d'infections virales et bactériennes. Plus particulièrement, l'invention concerne un immunoessai qui distingue rapidement les infections virales et/ou bactériennes, le marqueur viral étant la protéine mx-b induite par l'interféron et les marqueurs bactériens étant crp/pct/bpi.
MA50113A 2017-11-22 2018-05-15 Procédé et dispositif de discrimination entre des infections virales et bactériennes MA50113B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17203120.5A EP3489686B1 (fr) 2017-11-22 2017-11-22 Procédé et dispositif permettant de faire la distinction entre des infections virales et bactériennes
PCT/EP2018/062466 WO2019101370A1 (fr) 2017-11-22 2018-05-15 Procédé et dispositif de discrimination entre des infections virales et bactériennes

Publications (2)

Publication Number Publication Date
MA50113A1 true MA50113A1 (fr) 2020-08-31
MA50113B1 MA50113B1 (fr) 2021-02-26

Family

ID=60661707

Family Applications (1)

Application Number Title Priority Date Filing Date
MA50113A MA50113B1 (fr) 2017-11-22 2018-05-15 Procédé et dispositif de discrimination entre des infections virales et bactériennes

Country Status (31)

Country Link
US (2) US20200371095A1 (fr)
EP (1) EP3489686B1 (fr)
JP (1) JP6961101B2 (fr)
KR (1) KR102330236B1 (fr)
CN (1) CN111656191B (fr)
AU (1) AU2018373176B2 (fr)
BR (1) BR112020010245A2 (fr)
CA (1) CA3083305A1 (fr)
CL (1) CL2020001359A1 (fr)
CO (1) CO2020006252A2 (fr)
CU (1) CU24620B1 (fr)
CY (1) CY1124005T1 (fr)
DK (1) DK3489686T3 (fr)
EA (1) EA202091301A1 (fr)
ES (1) ES2851798T3 (fr)
HR (1) HRP20210495T1 (fr)
HU (1) HUE054089T2 (fr)
IL (1) IL274768B2 (fr)
LT (1) LT3489686T (fr)
MA (1) MA50113B1 (fr)
MX (1) MX2020005340A (fr)
MY (1) MY201966A (fr)
PL (1) PL3489686T3 (fr)
PT (1) PT3489686T (fr)
RS (1) RS61621B1 (fr)
SA (1) SA520412020B1 (fr)
SG (1) SG11202004591YA (fr)
SI (1) SI3489686T1 (fr)
SM (1) SMT202100193T1 (fr)
UA (1) UA125669C2 (fr)
WO (1) WO2019101370A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2851798T3 (es) 2017-11-22 2021-09-08 Dewact Labs GmbH Método y dispositivo para discriminar entre infecciones virales y bacterianas
CN116083525A (zh) * 2021-11-05 2023-05-09 湖南早晨纳米机器人有限公司 一种bhcr免疫交链式反应检测试剂及方法
KR20250075010A (ko) * 2023-11-21 2025-05-28 바디텍메드(주) 믹소바이러스 내성 단백질 a와 c-반응성 단백질을 이용한 박테리아감염과 바이러스감염 구별을 위한 진단 시스템

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6522794A (en) * 1993-03-22 1994-10-11 Incyte Pharmaceuticals, Inc. Use of bactericidal/permeability increasing protein and lipopolysaccharide binding protein levels and ratios thereof in diagnosis
US5466580A (en) 1993-09-22 1995-11-14 Xoma Corporation Method for quantifying BPI in body fluids
ATE363072T1 (de) * 1996-10-31 2007-06-15 Wussow Peter Von Monoklonaler antikörper gegen mxa und mxb
US6924153B1 (en) 1997-03-06 2005-08-02 Quidel Corporation Quantitative lateral flow assays and devices
EP1110970B1 (fr) 1999-12-22 2008-05-14 Dade Behring Marburg GmbH Anticorps anti-procalcitonin, procédé de production et utilisation
KR20050040866A (ko) * 2002-06-11 2005-05-03 아이다호 리서치 파운데이션 바이러스 감염의 검출을 위한 ⅰ형 인터페론-유도성 단백질
US7300802B2 (en) * 2003-04-25 2007-11-27 Biodigit Laboratories Corp. Membrane strip biosensor system for point-of-care testing
US8614101B2 (en) 2008-05-20 2013-12-24 Rapid Pathogen Screening, Inc. In situ lysis of cells in lateral flow immunoassays
US7658922B2 (en) 2005-06-24 2010-02-09 Ab Enzymes Gmbh Monoclonal antibodies, hybridoma cell lines, methods and kits for detecting phytase
WO2007082259A2 (fr) * 2006-01-11 2007-07-19 The University Of Wyoming Marqueurs de remplacement pour infections virales et autres réponses inflammatoires
SG177956A1 (en) * 2006-08-11 2012-02-28 Baylor Res Inst Gene expression signatures in blood leukocytes permit differential diagnosis of acute infections
US9910036B2 (en) * 2008-05-20 2018-03-06 Rapid Pathogen Screening, Inc. Method and device for combined detection of viral and bacterial infections
WO2011053832A1 (fr) * 2009-10-29 2011-05-05 The Trustees Of Columbia University In The City Of New York Utilisation de la protéine ngal urinaire à des fins de diagnostic d'une septicémie chez des bébés de très petit poids de naissance
US20130165470A1 (en) * 2011-12-21 2013-06-27 The Procter & Gamble Company Methods for Detecting and Treating Rhinovirus Infection
JP6293797B2 (ja) * 2013-03-07 2018-03-14 ラピッド パトゲン スクリーニング，インク． 転換領域を持つ複数面の側方流動アッセイ
DE102015100845A1 (de) 2015-01-21 2016-07-21 Gottfried Wilhelm Leibniz Universität Hannover Optisches Sensorsystem
CN105242049A (zh) * 2015-09-15 2016-01-13 安云庆 一种鉴别诊断急性支原体、细菌和病毒感染的试剂盒及其应用
US10808287B2 (en) 2015-10-23 2020-10-20 Rapid Pathogen Screening, Inc. Methods and devices for accurate diagnosis of infections
CN109844532B (zh) 2016-08-10 2022-06-17 米密德诊断学有限公司 分析生物数据的系统和方法
ES2851798T3 (es) 2017-11-22 2021-09-08 Dewact Labs GmbH Método y dispositivo para discriminar entre infecciones virales y bacterianas

Also Published As

Publication number Publication date
HRP20210495T1 (hr) 2021-11-12
PL3489686T3 (pl) 2021-08-30
SI3489686T1 (sl) 2021-04-30
CY1124005T1 (el) 2022-05-27
DK3489686T3 (da) 2021-03-22
LT3489686T (lt) 2021-04-12
JP2021504723A (ja) 2021-02-15
CL2020001359A1 (es) 2021-02-26
KR20200098541A (ko) 2020-08-20
AU2018373176A1 (en) 2020-06-04
SA520412020B1 (ar) 2024-02-15
SMT202100193T1 (it) 2021-05-07
CU20200043A7 (es) 2021-03-11
JP6961101B2 (ja) 2021-11-05
US20200371095A1 (en) 2020-11-26
ES2851798T3 (es) 2021-09-08
IL274768A (en) 2020-07-30
IL274768B1 (en) 2023-11-01
CN111656191A (zh) 2020-09-11
US20220404346A1 (en) 2022-12-22
WO2019101370A1 (fr) 2019-05-31
CA3083305A1 (fr) 2019-05-31
SG11202004591YA (en) 2020-06-29
CO2020006252A2 (es) 2020-08-10
UA125669C2 (uk) 2022-05-11
HUE054089T2 (hu) 2021-08-30
CN111656191B (zh) 2023-11-14
EP3489686B1 (fr) 2020-12-30
BR112020010245A2 (pt) 2020-11-10
IL274768B2 (en) 2024-03-01
MY201966A (en) 2024-03-27
EP3489686A1 (fr) 2019-05-29
MX2020005340A (es) 2020-10-14
PT3489686T (pt) 2021-02-12
CU24620B1 (es) 2022-09-08
EA202091301A1 (ru) 2020-08-19
KR102330236B1 (ko) 2021-11-24
MA50113B1 (fr) 2021-02-26
US12332242B2 (en) 2025-06-17
RS61621B1 (sr) 2021-04-29
AU2018373176B2 (en) 2025-04-10

Similar Documents

Publication Publication Date Title
MA50113A1 (fr) Procédé et dispositif de discrimination entre des infections virales et bactériennes
MA46731A (fr) Anticorps anti-tmprss2 et fragments de liaison à l'antigène
CA3087915C (fr) Identification par résolution de base sans bisulfite de modifications de cytosine
WO2018195427A3 (fr) Virothérapie oncolytique et immunothérapie
Deng et al. Cryptosporidium uses CSpV1 to activate host type I interferon and attenuate antiparasitic defenses
EP4408278A4 (fr) Système de détection d'analyte
EP3891513A4 (fr) Système intégré pour la détection et l'analyse de vibrations
WO2019060918A8 (fr) Dosages immunologiques pour la détection de protéines ran
EA202191931A1 (ru) Способ характеризации видимых и/или невидимых частиц в биологических препаратах
Hartady et al. Clinical human brucellosis in Malaysia: a case report
Velásquez et al. First case report of infection caused by Encephalitozoon intestinalis in a domestic cat and a patient with AIDS
Chauhan et al. CD4+ ICOS+ Foxp3+: a sub-population of regulatory T cells contribute to malaria pathogenesis
FR3023610B1 (fr) Systeme de traitement pour l'analyse de transport
Van Den Ham et al. Iron prevents the development of experimental cerebral malaria by attenuating CXCR3-mediated T cell chemotaxis
WO2019012481A3 (fr) G-quadruplexes divisés pour la capture et la détection d'acides nucléiques
Wagnerová et al. Humoral immune response and spreading of Encephalitozoon cuniculi infection in experimentally infected ponies
WO2019118721A3 (fr) Ligands non-anticorps pour la détection de protéines cibles
Sengupta et al. Development of an antigen ELISA using monoclonal antibodies against recombinant VSG for the detection of active infections of Trypanosoma evansi in animals
BRPI0208021B8 (pt) genes de antígeno ii de carcinoma de células escamosas rearranjados
EP3775842A4 (fr) Procédés et compositions pour déterminer la présence ou l'absence d'aberrations d'adn
WO2016168741A3 (fr) Détection de cytomégalovirus humain
FR3050045B1 (fr) Procede et systeme de separation de documents lors d'une numerisation par lot
MA41081B1 (fr) Système et procédé de signalisation de déviation de la circulation
EP3845908A4 (fr) Système de traitement d'échantillon
ATE426038T1 (de) Nachweis des rinderdiarrhoevirus in haarproben